Chedid Capital joins Ascoma to boost returns from insurance business
By Nikita Chaurasia  Date: 2020-09-07

Chedid Capital joins Ascoma to boost returns from insurance business

U.S.-based medical group Husson Family has reportedly entered a joint venture agreement with Lebanese insurance and financial service provider, Chedid Capital Holding for the transfer of control of Ascoma (Ascoma Assureurs Conseils).

As per the agreement, the Husson Family will be a majority stakeholder of Ascoma and will complete the transaction once the companies procure regulatory approval.

For those unfamiliar, Ascoma is a leading insurance brokerage company that primarily operates in Africa with over 23 subsidiaries across 21 countries. The company of around 780 employees, offers services that revolve around insurance broking for healthcare as well as P&C and cost management for healthcare companies.

According to credible sources, the transfer of control will enable Chedid Capital to manage the activities of Ascoma in Africa, while the Husson Family will continue to offer brokerage services in France and Monaco.

It appears that the merger is an display of Chedid Capital’s aim of becoming a leading insurance service provider in Middle East & Africa market, which the company believes could turn out to be a lucrative opportunity.

President of Ascoma, Hervé Husson was reported stating that with Chedid’s integrity, reliability, and professionalism, the acquisition will accelerate the growth of the company in Africa, while allowing them to focus on their development in France and Monaco.

Farid Chedid, Chairman and Founder of Chedid Captial Holding mentioned in a comment that the new venture will not only help Ascoma become a leading insurance brokerage firm in Middle East & Africa but also will be conducive to the interests of the company’s clients as well as partners.

The terms of the recent acquisition were not disclosed.

About Chedid Capital Holding

Since its inception in 2006, Lebanon-based Chedid Capital Holding offers insurance and reinsurance services in the Middle East, as well as Africa, Europe, and South-East Asia.

 

Source Credits: https://www.prnewswire.co.uk/news-releases/chedid-capital-and-ascoma-group-join-forces-to-create-a-leader-in-insurance-broking-in-the-middle-east-and-africa-814595803.html

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...